Neurocognitive safety after 96 weeks on dual therapy with atazanavir / ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial
FI: 5,217
Type: Article
Collaboration
Year: 2018
Writers
Perez-Valero, I; Pasquau, J; Rubio, R; Rivero, A; Santos, J; Sanz, J; Marino, A; Crespo, M; Hernandez-Quero, J; Iribarren, J.A.; Gutierrez, F; Terron, A; Stephen, H.; Perez-Molina, J.A.
Magazine
Title: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Quartile
- D1